The US Food and Drug Administration’s Office of Prescription Drug Promotion plans to examine the treatment preferences of consumers and physicians as they weigh the tradeoffs between a product’s efficacy, risks and other characteristics.
The agency’s new research project, “Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion,” is to...